Big Pharma

Cardiac Surgeon Dilek Gürsoy Speaks About Realheart's Artificial Heart at Impact LECH Cardiac surgeon Dilek Gürsoy is one of several top-notch speakers at Impact LECH, taking place June 15-18 in Austria. Dr. Gürsoy speaks about artificial hearts in general and about the Realheart artificial heart specifically. She will also participate in a panel discussion on the theme "Man and machine in medicine". Dr. Gürsoy was the first female surgeon in Europe to implant an artificial heart and is one of several prominent cardiac surgeons involved in Realheart's animal studies. Dr. Gürsoy has nearly 20 years of experience in cardiac surgery...

Gradientech presents QuickMIC® results at ASM Microbe 2023 Gradientech announces the presentation of promising results from two collaborative studies on its ultra-rapid diagnostic system QuickMIC® at ASM Microbe in Houston, Texas 15 - 19 June 2023. Organized by the American Society for Microbiology, ASM Microbe is one of the largest microbial sciences conferences bringing together scientists, researchers, and healthcare professionals in the US. “We are very proud to present QuickMIC data and showcase our system for leading experts in the field. QuickMIC is the fastest phenotypic antibiotic susceptibility testing (AST) system for sepsis samples on the market today with results...

Light physical activity from childhood is more effective than MVPA in reducing inflammation caused by being sedentary Increased sedentary time from childhood through young adulthood worsened low-grade inflammation in a new follow-up study. However, the results also showed that light physical activity (LPA) may completely reverse the adverse process. Moderate-to-vigorous physical activity (MVPA) did not have a similar effect. The study was conducted in collaboration between the University of Bristol in the UK, the University of Exeter in the UK, and the University of Eastern Finland, and the results were published in the Journal of Clinical Endocrinology & Metabolism. Low-grade...

A protective Alzheimer’s disease genetic variant has beneficial effects on amyloid-beta metabolism A new study conducted by researchers at the University of Eastern Finland discovered that the APP A673T genetic variant, which protects against Alzheimer’s disease, alters levels of several proteins and peptides linked to amyloid-beta metabolism in human biofluids and cell culture models, including amyloid beta itself. These new data support the idea that even a modest reduction in the beta-amyloidogenic processing of APP may be a feasible strategy for the prevention of Alzheimer's disease. Alzheimer’s disease (AD) is the most common form of dementia with more than 40...

VIRGIN ATLANTIC PARTNERS WITH CARDIOSECUR TO FURTHER ENHANCE IN-FLIGHT MEDICAL SAFETY     Airline continues its commitment to customer safety and innovation through latest investment with CardioSecur Virgin Atlantic remains the UK’s only airline to have 12 lead ECG capability in-flight It was the first airline in the world to have a fully ECG equipped fleet   Virgin Atlantic is upgrading its on-board safety equipment and bolstering its dedication to passenger health, thanks to a new partnership with CardioSecur, a pioneering medical tech provider from Germany.    From today, all flights will be equipped with the world’s smallest and lightest...